Paravertebral block pre and post procedure for Thoracic Outlet Syndrome

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Mayo Clinic in Florida, Jacksonville, FL
Thoracic Outlet Syndrome+1 More
Ropivacaine - Drug
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This research is being done to evaluate the effects of receiving only a paravertebral block prior to first rib resection procedure versus receiving the block both pre and post procedure.

Eligible Conditions

  • Thoracic Outlet Syndrome

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Other trials for Thoracic Outlet Syndrome

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Time of discharge (approximately 1 day), day 1 post-op, day 3 post-op, day 7 post-op, and day 14 post-op

Approximately 1 day
Length of stay
Day 14
Change in pain level
Change in quality of life

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Other trials for Thoracic Outlet Syndrome

Trial Design

2 Treatment Groups

Paravertebral block pre and post procedure
1 of 2
Paravertebral block pre procedure
1 of 2
Active Control

50 Total Participants · 2 Treatment Groups

Primary Treatment: Paravertebral block pre and post procedure · No Placebo Group · Phase 4

Paravertebral block pre and post procedure
Drug
ActiveComparator Group · 1 Intervention: Ropivacaine · Intervention Types: Drug
Paravertebral block pre procedure
Drug
ActiveComparator Group · 1 Intervention: Ropivacaine · Intervention Types: Drug

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: time of discharge (approximately 1 day), day 1 post-op, day 3 post-op, day 7 post-op, and day 14 post-op
Closest Location: Mayo Clinic in Florida · Jacksonville, FL
Photo of Jacksonville 1Photo of Jacksonville 2Photo of Jacksonville 3
2013First Recorded Clinical Trial
1 TrialsResearching Thoracic Outlet Syndrome
180 CompletedClinical Trials

Who is running the clinical trial?

Mayo ClinicLead Sponsor
2,860 Previous Clinical Trials
3,686,111 Total Patients Enrolled
Houssam Farres, MDPrincipal InvestigatorMayo Clinic
3 Previous Clinical Trials
42 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.